TOP OF THE NEWS
Siemens, GE Build Diagnostic Powerhouses
FDA to hold IVDMIA meeting
SCIENCE/TECHNOLOGY
New ACOG screening guidelines
FDA approves Chagas disease test
Screening newborns for SCID
MERGERS & ACQUISITIONS
Pfizer buys Genizon diagnostic rights
Luminex to buy Tm Bioscience
BD closes on TriPath Imaging
REIMBURSEMENT
Aetna, United will reimburse for OncotypeDX
JAMA study links reimbursement, clinical value of colon cancer screening
INSIDE DIAGNOSTICS INDUSTRY
Pharmacogenomics: Believe the hype?
PEOPLE
Epigenomics chooses new CEO
FINANCIAL NEWS
IVD stocks up 20% in 2006
G-2 INSIDER
Molecular diagnostics: the conference

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

February 2007 - Table of Contents

DTTR February 2007 (full PDF issue)

Siemens, GE Build Diagnostic Powerhouses

FDA to Hold Meeting on IVDMIA Draft Guidance

Pfizer Buys Diagnostic Rights for Genizon’s Disease Markers

New ACOG Guidelines Urge Earlier Screening for Down Syndrome

FDA Approves Ortho-Clinical’s Chagas Disease Screening Test

Initiative Seeks Routine SCID Screening for Newborns

Genomic Health Gets United, Aetna Reimbursement for Oncotype DX

Pharmacogenomics: Are Labs Believing the Hype?

JAMA Study Links Expanded Medicare Reimbursement With Increased Colon Cancer Screening, Earlier Diagnosis

Epigenomics Chooses New CEO, Contracts With Centocor for Cancer Biomarkers

Luminex to Buy Tm Bioscience for $37.9M

BD Closes on $350m TriPath Acquisition

IVD Stocks Rose 20% in 2006 Led by Immucor, Cholestech, Digene

Molecular Diagnostics: The Conference